基于m6A阅读器HNRNPA2B1升调和多种恶性瘤中的免疫透的预后模型的开发

Yang Han1, Wei Xia1,2, Zhong-Na Ma1

  • 1Department of Nuclear Medicine, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

PubMed
概括

高HNRNPA2B1表达与癌症发展和多种癌症类型的不良预后有关. 这种基因可以作为各种癌症的预后标记物和潜在的治疗标.